Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Tables)

v3.20.2
Accrued Expenses And Other Current Liabilities (Tables)
6 Months Ended
Jun. 30, 2020
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of accrued expenses and other current liabilities Accrued expenses and other current liabilities as of June 30, 2020 and December 31, 2019 consisted of the following: 
  As of
  June 30, 2020 December 31, 2019
Research and development expenses $ 1,899,830    $ 920,901   
Compensation and benefits 1,670,669    1,591,964   
General and administrative 912,943    360,016   
Sales and marketing 212,807    120,056   
Sales returns and allowances 1,144,427    2,284,175   
Medicaid rebates 101,458    118,271   
Lease liability, current 431,543    155,815   
Other 113,981    89,054   
Total accrued expenses and other current liabilities $ 6,487,658    $ 5,640,252